Latest Content

The Importance of Utilizing Support Networks Following a Cancer Diagnosis

February 10th 2025, 10:00pm

By Dr. John Oertle

Video

Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.

Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care

February 10th 2025, 8:00pm

By Ryan Scott

Article

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine dehydrogenase deficiency.

The Effects of Scanxiety on ‘Normal’ Life

February 10th 2025, 6:00pm

By Karen Cohn

Article

As a cancer survivor, I face added stress with an upcoming black belt test and "scanxiety" before my annual CT scan and oncology appointment.

An Expert Breaks Down What DPD Is and Labeling Updates From The FDA

February 10th 2025, 5:00pm

By Dr. Gabriel A. Brooks

Video

Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.

THIO and Libtayo Extends OS in NSCLC Following Progression on SOC Therapy

February 10th 2025, 4:00pm

By Ryan Scott

Article

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more standard-of-care regimens.

Lonsurf Shows Survival Benefit Over Placebo in Stage 4 Colorectal Cancer

February 10th 2025, 2:00pm

By Kristi Rosa

Article

In patients with residual disease after curative resection of colorectal cancer, Lonsurf showed a numerical improvement in DFS, though not significant.

Pelareorep With Chemo and Tecentriq Shows Acceptable Safety in Metastatic PDAC

February 9th 2025, 7:00pm

By Kristi Rosa

Article

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma.

From Patient 3737 to Advocate: The Life-Changing Power of Clinical Trials

February 9th 2025, 3:00pm

By Melinda Bachini

Article

Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of cholangiocarcinoma.

Reoperations May Offer Survival Benefit in Recurrent Glioblastoma

February 8th 2025, 7:00pm

By Darlene Dobkowski, MA

Article

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

Braftovi Plus Erbitux With mFOLFOX6 May Improve Responses in BRAF V600E+ mCRC

February 8th 2025, 3:00pm

By Chris Ryan

Article

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

Tafinlar/Mekinist Combo is Safe, Effective in Patients With Glioma

February 7th 2025, 10:00pm

By Alex Biese

Article

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among patients with gliomas.

Tagrisso Associated With Cardiac Side Effects in Non-Small Cell Lung Cancer

February 7th 2025, 8:00pm

By Spencer Feldman

Article

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events and reduced overall survival.

The Doctors Who Healed Me: My Journey With Colon Cancer and Gratitude

February 7th 2025, 6:00pm

By Carla Deschamps

Article

My colon cancer journey showed me how compassionate doctors can change lives, as their kindness and care gave me strength and hope throughout my recovery.

Randy Moss Shares Cancer Update, “Squid Game” Star Dies and More

February 7th 2025, 4:00pm

By Alex Biese

Article

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is this week’s cancer news.

Neoadjuvant TKI Prior to Surgery Has Surgical Benefit in Non-Metastatic GIST

February 7th 2025, 2:00pm

By Ryan Scott

Article

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less invasive or complex surgeries.